E

European Healthcare Acquisition & Growth Company BV
AEX:EHCS

Watchlist Manager
European Healthcare Acquisition & Growth Company BV
AEX:EHCS
Watchlist
Price: 9.9 EUR 1.02% Market Closed
Market Cap: 198m EUR
Have any thoughts about
European Healthcare Acquisition & Growth Company BV?
Write Note

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of EHCS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EHCS Intrinsic Value
Not Available
E
Base Case Scenario
How do you feel about EHCS?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about European Healthcare Acquisition & Growth Company BV

Provide an overview of the primary business activities
of European Healthcare Acquisition & Growth Company BV.

What unique competitive advantages
does European Healthcare Acquisition & Growth Company BV hold over its rivals?

What risks and challenges
does European Healthcare Acquisition & Growth Company BV face in the near future?

Show all valuation multiples
for European Healthcare Acquisition & Growth Company BV.

Provide P/S
for European Healthcare Acquisition & Growth Company BV.

Provide P/E
for European Healthcare Acquisition & Growth Company BV.

Provide P/OCF
for European Healthcare Acquisition & Growth Company BV.

Provide P/FCFE
for European Healthcare Acquisition & Growth Company BV.

Provide P/B
for European Healthcare Acquisition & Growth Company BV.

Provide EV/S
for European Healthcare Acquisition & Growth Company BV.

Provide EV/GP
for European Healthcare Acquisition & Growth Company BV.

Provide EV/EBITDA
for European Healthcare Acquisition & Growth Company BV.

Provide EV/EBIT
for European Healthcare Acquisition & Growth Company BV.

Provide EV/OCF
for European Healthcare Acquisition & Growth Company BV.

Provide EV/FCFF
for European Healthcare Acquisition & Growth Company BV.

Provide EV/IC
for European Healthcare Acquisition & Growth Company BV.

Compare the intrinsic valuations
of European Healthcare Acquisition & Growth Company BV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of European Healthcare Acquisition & Growth Company BV against its competitors.

Analyze the profit margins
(gross, operating, and net) of European Healthcare Acquisition & Growth Company BV compared to its peers.

Compare the P/E ratios
of European Healthcare Acquisition & Growth Company BV against its peers.

Discuss the investment returns and shareholder value creation
comparing European Healthcare Acquisition & Growth Company BV with its peers.

Analyze the financial leverage
of European Healthcare Acquisition & Growth Company BV compared to its main competitors.

Show all profitability ratios
for European Healthcare Acquisition & Growth Company BV.

Provide ROE
for European Healthcare Acquisition & Growth Company BV.

Provide ROA
for European Healthcare Acquisition & Growth Company BV.

Provide ROIC
for European Healthcare Acquisition & Growth Company BV.

Provide ROCE
for European Healthcare Acquisition & Growth Company BV.

Provide Gross Margin
for European Healthcare Acquisition & Growth Company BV.

Provide Operating Margin
for European Healthcare Acquisition & Growth Company BV.

Provide Net Margin
for European Healthcare Acquisition & Growth Company BV.

Provide FCF Margin
for European Healthcare Acquisition & Growth Company BV.

Show all solvency ratios
for European Healthcare Acquisition & Growth Company BV.

Provide D/E Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide D/A Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Interest Coverage Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Altman Z-Score Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Quick Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Current Ratio
for European Healthcare Acquisition & Growth Company BV.

Provide Cash Ratio
for European Healthcare Acquisition & Growth Company BV.

What is the historical Revenue growth
over the last 5 years for European Healthcare Acquisition & Growth Company BV?

What is the historical Net Income growth
over the last 5 years for European Healthcare Acquisition & Growth Company BV?

What is the current Free Cash Flow
of European Healthcare Acquisition & Growth Company BV?

Discuss the annual earnings per share (EPS)
trend over the past five years for European Healthcare Acquisition & Growth Company BV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
European Healthcare Acquisition & Growth Company BV

Balance Sheet Decomposition
European Healthcare Acquisition & Growth Company BV

Current Assets 15.6m
Cash & Short-Term Investments 13.9m
Receivables 1.6m
Other Current Assets 86k
Current Liabilities 14m
Accounts Payable 1.1m
Other Current Liabilities 12.9m
Efficiency

Earnings Waterfall
European Healthcare Acquisition & Growth Company BV

Revenue
0 EUR
Operating Expenses
-1.3m EUR
Operating Income
-1.3m EUR
Other Expenses
5m EUR
Net Income
3.7m EUR

Free Cash Flow Analysis
European Healthcare Acquisition & Growth Company BV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

EHCS Profitability Score
Profitability Due Diligence

European Healthcare Acquisition & Growth Company BV's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

European Healthcare Acquisition & Growth Company BV's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

EHCS Solvency Score
Solvency Due Diligence

European Healthcare Acquisition & Growth Company BV's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
67/100
Solvency
Score

European Healthcare Acquisition & Growth Company BV's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EHCS Price Targets Summary
European Healthcare Acquisition & Growth Company BV

There are no price targets for EHCS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for EHCS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for EHCS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

European Healthcare Acquisition & Growth Company BV

Country

Germany

Industry

N/A

Market Cap

198m EUR

Dividend Yield

0%

Description

European Healthcare Acquisition & Growth Company BV is an operators-led special purpose acquisition company. The company is headquartered in Munich, Bayern. The company went IPO on 2021-11-18. The Firm’s business purpose is to effect a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm focuses its search for a potential target business in Europe, in such as Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics, as well as Life Science Tools.

Contact

BAYERN
Munich
Theresienhohe 28
www.ehc-company.com

IPO

2021-11-18

Employees

-

Officers

Director & CEO
Dr. Cornelius Baur
Chief Investment Officer & Director
Dr. Thomas Rudolph

See Also

Discover More